CLL cells in the murine spleen and the patient LN expressed significantly more activated BTK (Figure 3c; P=.005 and P=.02, respectively) than the corresponding CLL cells from the human PB used for xenografting. Here, BTK is linked to B-cell chronic lymphocytic leukemia.